Manns, Michael
Samuel, Didier
Gane, Edward J
Mutimer, David
McCaughan, Geoff
Buti, Maria
Prieto, Martín
Calleja, José Luis
Peck-Radosavljevic, Markus
Müllhaupt, Beat
Agarwal, Kosh
Angus, Peter
Yoshida, Eric M
Colombo, Massimo
Rizzetto, Mario
Dvory-Sobol, Hadas
Denning, Jill
Arterburn, Sarah
Pang, Phillip S
Brainard, Diana
McHutchison, John G
Dufour, Jean-François
Van Vlierberghe, Hans
van Hoek, Bart
Forns, Xavier
Funding for this research was provided by:
Gilead Sciences
This article is maintained by: Elsevier
Article Title: Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Journal Title: The Lancet Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1473-3099(16)00052-9
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1473-3099(16)00079-7
Content Type: article
Copyright: © 2016 Elsevier Ltd. All rights reserved.